Immunotherapy for

ALK ALK-rearrangements cancer vaccine immune evasion immunotherapy non-small cell lung cancer tyrosine kinase inhibitors

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 Mar 2021
Historique:
received: 26 02 2021
revised: 16 03 2021
accepted: 19 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

Rearrangements in the Anaplastic Lymphoma Kinase (

Identifiants

pubmed: 33806977
pii: cancers13061476
doi: 10.3390/cancers13061476
pmc: PMC8004790
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Prostate. 2009 Nov 1;69(15):1694-703
pubmed: 19670224
J Thorac Dis. 2018 May;10(Suppl 13):S1602-S1614
pubmed: 29951309
Lung Cancer. 2018 Nov;125:86-92
pubmed: 30429043
J Thorac Oncol. 2015 Jun;10(6):910-23
pubmed: 25658629
Nature. 2014 Dec 18;516(7531):423-7
pubmed: 25337876
Science. 1994 Mar 4;263(5151):1281-4
pubmed: 8122112
Sci Transl Med. 2012 Feb 8;4(120):120ra17
pubmed: 22277784
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20852-7
pubmed: 19088198
Ann Oncol. 2019 Aug 1;30(8):1321-1328
pubmed: 31125062
Cell. 2012 Sep 14;150(6):1121-34
pubmed: 22980976
Elife. 2015 Sep 29;4:e09811
pubmed: 26418745
Clin Lung Cancer. 2021 Jan;22(1):49-57
pubmed: 33250347
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15862-7
pubmed: 26630010
Clin Cancer Res. 2016 Sep 15;22(18):4585-93
pubmed: 27225694
Lancet Oncol. 2015 Jul;16(7):e342-51
pubmed: 26149886
Oncoimmunology. 2015 Dec 21;5(3):e1094598
pubmed: 27141355
Mol Cancer Res. 2009 Sep;7(9):1466-76
pubmed: 19737969
Lancet. 2016 Apr 9;387(10027):1540-1550
pubmed: 26712084
FASEB J. 2019 Nov;33(11):12487-12499
pubmed: 31431076
Clin Cancer Res. 2015 Sep 1;21(17):4014-21
pubmed: 26019170
Cell. 2007 Dec 14;131(6):1190-203
pubmed: 18083107
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Cell Rep. 2014 Nov 20;9(4):1219-27
pubmed: 25456124
Sci Transl Med. 2012 Mar 28;4(127):127ra37
pubmed: 22461641
Blood. 2009 Aug 20;114(8):1537-44
pubmed: 19423728
PLoS One. 2012;7(2):e31323
pubmed: 22347464
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Mol Ther. 2017 Sep 6;25(9):2189-2201
pubmed: 28676342
Clin Cancer Res. 2008 Jul 1;14(13):4275-83
pubmed: 18594010
Clin Cancer Res. 2011 Jul 1;17(13):4232-44
pubmed: 21540239
Cancer Immunol Res. 2015 Dec;3(12):1333-1343
pubmed: 26419961
Oncotarget. 2017 Jul 4;8(27):44960-44975
pubmed: 28402953
Ann Oncol. 2016 Aug;27(8):1492-504
pubmed: 27207108
Oncogene. 2008 Oct 6;27(45):5904-12
pubmed: 18836471
Blood. 2002 Mar 15;99(6):2100-6
pubmed: 11877285
Ther Adv Med Oncol. 2018 Jan 09;10:1758834017745012
pubmed: 29383034
Eur J Cancer. 2018 Sep;101:114-122
pubmed: 30053670
Cancer Biol Med. 2020 Aug 15;17(3):768-781
pubmed: 32944405
Curr Opin Immunol. 2015 Apr;33:101-11
pubmed: 25728990
Interdiscip Sci. 2019 Jun;11(2):266-272
pubmed: 31098955
Oncogene. 1997 Jan 30;14(4):439-49
pubmed: 9053841
Clin Cancer Res. 2011 Apr 15;17(8):2081-6
pubmed: 21288922
Clin Cancer Res. 2012 Mar 1;18(5):1472-82
pubmed: 22235099
Clin Cancer Res. 2014 Jul 15;20(14):3660-71
pubmed: 24788102
J Thorac Oncol. 2018 May;13(5):682-688
pubmed: 29518553
Oncologist. 2017 Dec;22(12):1444-1450
pubmed: 29079636
N Engl J Med. 2010 Oct 28;363(18):1734-9
pubmed: 20979473
Oncoimmunology. 2015 Oct 29;5(3):e1108514
pubmed: 27141364
Trends Immunol. 2015 Apr;36(4):265-76
pubmed: 25797516
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
Cell Rep. 2017 Jan 3;18(1):248-262
pubmed: 28052254
Nat Med. 2002 Aug;8(8):793-800
pubmed: 12091876
Lancet. 2016 Apr 30;387(10030):1837-46
pubmed: 26970723
Nature. 2007 Aug 2;448(7153):561-6
pubmed: 17625570
Clin Cancer Res. 2009 Aug 15;15(16):5216-23
pubmed: 19671850
Clin Cancer Res. 2014 Apr 15;20(8):2029-34
pubmed: 24573551
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Annu Rev Immunol. 2004;22:329-60
pubmed: 15032581
J Exp Med. 2009 Dec 21;206(13):3015-29
pubmed: 20008522
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19893-7
pubmed: 19064915
J Thorac Dis. 2020 Aug;12(8):4516-4521
pubmed: 32944366
Cancers (Basel). 2020 Feb 12;12(2):
pubmed: 32059449
Ann Diagn Pathol. 2015 Dec;19(6):418-22
pubmed: 26321154
Mucosal Immunol. 2008 Sep;1(5):372-81
pubmed: 19079201
Ann Oncol. 2003 Mar;14(3):461-6
pubmed: 12598354
Oncol Lett. 2019 Feb;17(2):2020-2030
pubmed: 30675269
Int J Cancer. 2006 Feb 1;118(3):688-95
pubmed: 16114011

Auteurs

Kamya Sankar (K)

Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109-5848, USA.

Sunitha Nagrath (S)

Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109-5848, USA.
Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109-5848, USA.

Nithya Ramnath (N)

Division of Medical Oncology, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI 48109-5848, USA.

Classifications MeSH